期刊文献+

国产厄贝沙坦对老年原发性高血压的疗效及对肾功能保护作用的研究

The effects of domestic irbesartan on blood pressure and renal function in the aged with primary hypertension
下载PDF
导出
摘要 目的 评价国产厄贝沙坦对老年原发性高血压的疗效及对肾功能的保护作用。方法42例确诊为原发性高血压的老年患者,服用国产厄贝沙坦150mg,每日1次,每1~2周随访1次,若服药后降压效果不理想,可加大至300mg/d,治疗8周,监测治疗前后24h动态血压水平及肾功能指标。结果 国产厄贝沙坦治疗后,患者24h平均收缩压和舒张压、日间及夜间收缩压和舒张压均有明显下降(P〈0.05或〈0.01);血及尿β2-微球蛋白明显减少[(5.9±3.3)μg/L比(2.6±2.6)μg/L,(811.2±97.2)mmol/L比(457.6±69.8)mmol/L]。结论 国产厄贝沙坦不仅对老年原发性高血压患者有良好的平稳降压效果,而且对其肾功能亦有良好的保护作用。 Objective To evaluate the effects of domestic irbesartan on blood pressure and renal function in the aged with primary hypertension. Methods Renal function, plasma and urine β2 microglobulin was measured and blood pressure was investigated by 24-hour ambulatory blood monitoring in 42 aged with primary hypertension who received domestic irbesartan ( 150 mg/d, followed up every 1-2 weeks. If the effect was not ideal, the dose could be added to 300 mg/d) in 8-week' s treatment. Results After the treatment, 24 hours mean systolic blood pressure, 24-hour mean diastolic blood pressure, mean day systolic blood pressure, mean day diastolic blood pressure, mean night systolic blood pressure, mean night diastolic blood pressure were significantly reduced. At the same time, domestic irbesartan induced a remarkable reduction of plasma and urine 13 2 microglobulin [ (5.9± 3.3 ) μg/L vs ( 2.6± 2.6) μg/L, (811.2 ± 97.2 ) mmol/L vs (457.6 ±69.8)mmol/L,respectively]. Conclusion The antihypertensive effects of domestic irbesartan can persist for 24-hour and can reduce urinary protein.
出处 《中国医师进修杂志(内科版)》 2008年第6期14-15,共2页 Chinese Journal of Postgraduates of Medicine
关键词 老年人 高血压 Β2-微球蛋白 厄贝沙坦 Aged Hypertension Beta 2-microglobulin Irbesartan
  • 相关文献

参考文献4

  • 1杨溢,银翠云,龚卫东,杨昱,陆秀红.动态血压监测对老年高血压病的诊断价值及其临床意义[J].临床内科杂志,2005,22(7):449-450. 被引量:6
  • 2Zanehetti A. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents. J Hypertension, 1999,13 Suppl 2: S21-25.
  • 3White WB, Lund-Johansen P, Omvik P. Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy. J Hypertension , 1993,11 Suppl 4:S75-79.
  • 4Sasamura H.Prevention of hypertensive renal damage by prepubertal treatment with ARB. Nippon Rinsho,2002,60( 10):1962-1967.

二级参考文献5

  • 1Brien EO, Asmar R, Beilin L, et al. European society of hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens ,2003,21:821-848.
  • 2WHO-ISH hypertension guidelines committee. 1999 WHO-ISH Guidelines for the management of hypertension. J Hypertens, 1999,17:151-183.
  • 3Bloch A. Is white-coat hypertension a disease? Schweiz Rundsch Med Prax, 1997,86:6-8.
  • 4Staessen JA,Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in European Trial Investigations. JAMA ,2000,283:475-476.
  • 5Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension ,2000,36: 894 -900.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部